Results 141 to 150 of about 3,282 (184)

Comparison of granisetron and palonosetron in triplet anti-emetic prophylaxis in non-small cell lung cancer patients receiving cisplatin-based highly emetogenic chemotherapy. [PDF]

J Oncol Pharm Pract
Araz M, Beypinar I, Inci F, Koral L, Kocak MZ, Korkmaz M, Demirkiran A, Eryilmaz MK, Artac M.   +8 more
europepmc   +1 more source

Nausea and vomiting in an evolving anticancer treatment landscape: long-delayed and emetogenic antibody-drug conjugates. [PDF]

Future Oncol
Park YH, Bianchini G, Cortés J, Licata L, Vidal M, Iihara H, Roeland EJ, Jordan K, Scotté F, Schwartzberg L, Navari RM, Aapro M, Rugo HS.   +12 more
europepmc   +1 more source

Guidance on the short hydration method for cisplatin administration. [PDF]

Int J Clin Oncol
Ninomiya K, Kunimasa K, Kurata Y, Sato Y, Fujisaka Y, Ishikawa H, Hotta K.   +6 more
europepmc   +1 more source

Antiemetic medications for preventing chemotherapy-induced nausea and vomiting in children: a systematic review and Bayesian network meta-analysis. [PDF]

Support Care Cancer
Walker R, Dias S, Phillips RS.
europepmc   +1 more source

Formulation development and In vivo evaluation of mouth dissolving films containing Palonosetron HCl

, 2016
Jyothi Sri S, Darna Biksha Pathi
openalex   +1 more source

A multicenter randomized open-label phase 2 study investigating optimal antiemetic therapy for patients with advanced/recurrent gastric cancer treated with trastuzumab deruxtecan: the EN-hance study. [PDF]

Int J Clin Oncol
Aoyama T, Ooki A, Oba K, Nishikawa K, Kawabata R, Honda M, Maeda H, Kanda M, Sugiyama K, Makiyama A, Segami K, Takahashi M, Shindo Y, Namikawa T, Oshima T, Katayama A, Shiosakai K, Sakamoto J.   +17 more
europepmc   +1 more source

Refractory Nausea and Vomiting Due to Central Nervous System Injury: A Focused Review. [PDF]

Life (Basel)
Stoica S, Hogge C, Theeler BJ.
europepmc   +1 more source

Atypical Femoral Fracture During Long-Term Treatment With Denosumab in Patients With Metastatic Bone Tumors. [PDF]

Cureus
Aimono Y, Sunaga T, Yonezawa R, Tsuboya A, Kogo M, Itoh A.   +5 more
europepmc   +1 more source

Dexamethasone-sparing strategies in anthracycline and cyclophosphamide-based chemotherapy with a focus on 5-HT3 receptor antagonists: a network meta-analysis. [PDF]

Front Oncol
Watanabe D, Iihara H, Kobayashi R, Fujii H, Mori R, Kumada K, Shimizu M, Futamura M, Suzuki A.   +8 more
europepmc   +1 more source

New drugs: Palonosetron hydrochloride

Australian Prescriber, 2011
openaire   +1 more source